Article contents
A Double-Blind Out-Patient Trial of Indalpine vs Mianserin
Published online by Cambridge University Press: 29 January 2018
Summary
Indalpine 150 mg per day and mianserin 60 mg per day were compared in a double-blind study of 65 depressed out-patients: 52 patients completed the 4-week trial. At the end of four weeks there was no significant difference in antidepressant effect between the two drugs; but in the first two weeks, improvement in the mianserin-treated group was significantly greater than that in the indalpine group. The mianserin-treated group reported more side-effects of sedation (eg. drowsiness, clumsiness, heaviness of limbs etc.) and one patient on indalpine developed a mild leucopenia.
- Type
- Papers
- Information
- Copyright
- Copyright © 1985 The Royal College of Psychiatrists
References
- 6
- Cited by
eLetters
No eLetters have been published for this article.